Binding of the anti-inflammatory drug niflumic acid to bovine serum albumin
- PMID: 2101318
Binding of the anti-inflammatory drug niflumic acid to bovine serum albumin
Abstract
Binding of the anti-inflammatory drug niflumic acid to serum albumin was measured by equilibrium dialysis and the dissociation constants were determined. The maximal binding capacity was 36 mol niflumic acid per mol albumin. Most of the binding sites were of low affinity, only six having dissociation constants below 1 mM. At the plasma concentrations most frequently used in experimental work, the high affinity sites account for more than 99% of the albumin-bound niflumic acid.
Similar articles
-
Intracellular binding of the anti-inflammatory drug niflumic acid in the liver.Res Commun Mol Pathol Pharmacol. 1995 Sep;89(3):411-9. Res Commun Mol Pathol Pharmacol. 1995. PMID: 8680809
-
Transport, distribution space and intracellular concentration of the anti-inflammatory drug niflumic acid in the perfused rat liver.Biochem Pharmacol. 1993 May 5;45(9):1863-71. doi: 10.1016/0006-2952(93)90445-3. Biochem Pharmacol. 1993. PMID: 8494546
-
Inhibition of hepatic gluconeogenesis by niflumic acid correlates with the concentration of the free form.Res Commun Chem Pathol Pharmacol. 1993 May;80(2):241-8. Res Commun Chem Pathol Pharmacol. 1993. PMID: 8321924
-
Stereospecificity of triiodothyronine transport into brain, liver, and salivary gland: role of carrier- and plasma protein-mediated transport.Endocrinology. 1987 Sep;121(3):1185-91. doi: 10.1210/endo-121-3-1185. Endocrinology. 1987. PMID: 3622378
-
[Derivative spectrophotometric and NMR spectroscopic study in pharmaceutical science].Yakugaku Zasshi. 2007 Oct;127(10):1621-42. doi: 10.1248/yakushi.127.1621. Yakugaku Zasshi. 2007. PMID: 17917421 Review. Japanese.